Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 22, 2023

Glycaemic Control, Risk of Hypoglycaemia, and All-Cause Mortality in New Users of Second-Generation Basal Insulin With Type 2 Diabetes and Chronic Kidney Disease



Additional Info

Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
Diabetologia 2023 Oct 01;66(10)1908-1913, V Kosjerina, B Carstensen, H Amadid, D Vistisen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading